83.450
83.45 (0%)
As of Dec 20, 2024
Intra-Cellular Therapies, Inc. [ITCI]
Source:
Company Overview
Intra-cellular Therapies, Inc is a biopharmaceutical company focused on the discovery, clinical development and commercialization of innovative, small molecule drugs that address underserved medical needs primarily in neuropsychiatric and neurological disorders by targeting intracellular signaling mechanisms within the central nervous system, or CNS.
Country | United States |
Headquarters | new york, new york |
Phone Number | 212-923-3344 |
Industry | manufacturing |
CEO | Sharon Mates, Ph.D. |
Website | www.intracellulartherapies.com |